Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ciphergen Biosystems(CIPH): -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (240)	7/13/2004 12:39:26 PM
From: tuck	Respond to of 510

>>Any ideas how this might stack up against the Agilent product ? Tuck ?<< Not sure. These would seem to complement or supplant the BioSepra beads: ciphergen.com >>Library bead treatment of serum followed by expression profiling using ProteinChip® technology has been shown to provide improved detection of low abundance proteins and increase the number of total proteins detected, both important aspects leading to improved biomarker and drug target discovery.<< I haven't seen studies involving either one. The Agilent columns are already out there, though not super cheap or long lasting. If this can beat on cost/performance ratio, then fine. Perhaps the strategy is to offer an alternative package without tripping on Agilent's IP. Cheers, Tuck